AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3275909
Drug: ethinyl estradiol
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ethinyl estradiol 35 micrograms plus norethindrone 1 mg
Trial: 3275909
Drug: ethinyl estradiol
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ethinyl estradiol 35 micrograms plus norethindrone 0.5 and 1 mg (biphasic)
Trial: 24711000
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 100mg/kg/day as intermittent intravenous infusion from day -6 to day +15
Trial: 16995478
Drug: Surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery plus preoperative IL-2 administration (19 patients)
Trial: 8636768
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (carmustine, etoposide, cytarabine, and cyclophosphamide [BEAC]) followed by autologous bone marrow transplantation (ABMT)
Trial: 1619995
Drug: Naloxone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.8 mg bolus followed by 0.04 mg/kg/h infusion)
Trial: 30955478
Drug: Educational text
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational text messages about osteoporosis (daily for one month)
Trial: 19056011
Drug: Drotrecogin α
RxNorm normalized name: Drotrecogin Alfa
DrugBank: Drotrecogin alfa (DB00055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drotrecogin α (activated) treatment
Trial: 7603811
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil suspension (20 mg/kg/day twice daily for 4 days)
Trial: 7603811
Drug: Penicillin suspension
RxNorm normalized name: Penicillin V
DrugBank: Meticillin (DB01603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin suspension (45 mg/kg/day divided three times daily for 10 days)
Trial: 28514299
Drug: Buprenorphine transdermal
RxNorm normalized name: Buprenorphine Transdermal System
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine transdermal patch
Trial: 28514299
Drug: Parecoxib intravenous
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib intravenous injection (Group A)
Trial: 28514299
Drug: Oral celecoxib
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral celecoxib (Group B)
Trial: 26573452
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (20 intermittent presses to the patella and olecranon)
Trial: 18523893
Drug: Standardized advice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized advice and a dose tapering schedule
Trial: 14627859
Drug: 17beta-estradiol gel
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol gel 2.5 g (1.5 mg estradiol)
Trial: 14627859
Drug: 17beta-estradiol gel
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol gel 1.25 g (0.75 mg estradiol)
Trial: 14627859
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (17beta-estradiol gel 2.5 g, 17beta-estradiol gel 1.25 g, placebo)
Trial: 11566168
Drug: 10‐mg atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐mg atorvastatin
Trial: 8053744
Drug: Glutamine-supplemented TPN
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-supplemented TPN (0.18 g of glutamine/kg/d)
Trial: 8053744
Drug: Conventional TPN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional TPN (0.2 g nitrogen/kg/d)
Trial: 2965375
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (CY 222) at a fixed dose of 750 anti-Xa units
Trial: 2965375
Drug: Standard heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard heparin at a dose of 500 IU/kg/24 h
Trial: 8345416
Drug: Somatotropin, 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatotropin, 0.3 mg/kg per week, administered subcutaneously three times weekly (n = 63)
Trial: 8345416
Drug: Daily dosing
RxNorm normalized name: Osmolex 322 MG Daily Dosing Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dosing of somatotropin (n = 92)
Trial: 8345416
Drug: Three-times-weekly dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-times-weekly dosing of somatotropin (n = 92)
Trial: 76842
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cyclophosphamide, 5‐fluorouracil, and prednisone (C.F.P.) with or without radiotherapy
Trial: 26666258
Drug: MEDI-551, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI-551, a monoclonal antibody that depletes CD19+ B-cells
Trial: 12021573
Drug: Tezosentan 100
RxNorm normalized name: TEZOSENTAN
DrugBank: Tezosentan (DB06558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan 100 mg
Trial: 12021573
Drug: Tezosentan 200
RxNorm normalized name: TEZOSENTAN
DrugBank: Tezosentan (DB06558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan 200 mg
Trial: 12021573
Drug: Tezosentan 400
RxNorm normalized name: TEZOSENTAN
DrugBank: Tezosentan (DB06558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan 400 mg
Trial: 12021573
Drug: Tezosentan 600
RxNorm normalized name: TEZOSENTAN
DrugBank: Tezosentan (DB06558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan 600 mg
Trial: 12021573
Drug: Tezosentan (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan (all doses)
Trial: 8007742
Drug: L-Thyroxin Henning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Thyroxin Henning
Trial: 8007742
Drug: Another tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Another tablet preparation
Trial: 8007742
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution of levothyroxine (reference solution)
Trial: 2509007
Drug: Calcitonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitonin treatment (100 U by subcutaneous self-application on alternate days for 6-8 weeks)
Trial: 2509007
Drug: Cyclical hormone
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclical hormone replacement therapy (over 12 months)
Trial: 2509007
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (analgetic treatment and 500 mg Ca daily)
Trial: 1099526
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of ASA
Trial: 1099526
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of lactose (placebo)
Trial: 23553060
Drug: Heparin lock
RxNorm normalized name: Heparin Lock Flush
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin lock (300 U/3 ml)
Trial: 22212315
Drug: Intermittent bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent bolus epidural of 2 mg/10 mL morphine
Trial: 15385829
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of micronized 17beta‐estradiol valerate (E2V)
Trial: 15385829
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of E2V in combination with 5 mg of medroxyprogesterone acetate (MPA)
Trial: 9410554
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin analog
Trial: 26862625
Drug: Fentanyl-bupivacaine-morphine
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl-bupivacaine-morphine
Trial: 16645357
Drug: Valsartan (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (titrated up to 320 mg)
Trial: 8912074
Drug: Early definitive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early definitive treatment with antrectomy or pyloroplasty
Trial: 31137959
Drug: Weekly real-time
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly real-time adherence feedback via SMS using Wisepill device
Trial: 19541792
Drug: Oral casopitant
RxNorm normalized name: maropitant Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral casopitant 50 mg
Trial: 19541792
Drug: Oral casopitant
RxNorm normalized name: maropitant Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral casopitant 100 mg
Trial: 19541792
Drug: Oral casopitant
RxNorm normalized name: maropitant Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral casopitant 150 mg
Trial: 19541792
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral casopitant 150 mg
Trial: 16510744
Drug: Natalizumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natalizumab (300 mg, intravenous infusion every four weeks for more than two years)
Trial: 16510744
Drug: Placebo (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous infusion every four weeks for more than two years)
Trial: 12752404
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) intravenous infusion
Trial: 10956377
Drug: L-carnitine and
RxNorm normalized name: Fat Burner with Chromium Picolinate, L-Carnitine and Iron Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine and acetyl-L-carnitine
Trial: 29968301
Drug: salbutamol (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salbutamol (6 × 4 mg oral)
Trial: 21084036
Drug: rHuEPO plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO plus oral oxymetholone (50 mg/tablet twice daily)
Trial: 18958840
Drug: Atorvastatin and
RxNorm normalized name: atorvastatin and ezetimibe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin and pioglitazone combined treatment
Trial: 18958840
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with atorvastatin and pioglitazone
Trial: 30870770
Drug: Treatment As
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment As Usual (TAU; n = 11)
Trial: 29161988
Drug: Obligatory daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obligatory daily school-based physical activity (5×45 minutes per week)
Trial: 26886651
Drug: Dexmedetomidine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (loading of 1.0 μg/kg for 20 minutes before the termination of surgery)
Trial: 24576512
Drug: Faith-based therapeutic
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Faith-based therapeutic lifestyle change (TLC) intervention delivered through 11 weekly sessions and 3 monthly motivational interviewing sessions.
Trial: 24576512
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education (HE) control delivered through 11 weekly classes on hypertension and other health topics.
Trial: 23383460
Drug: Belt Vessel
RxNorm normalized name: acellular tissue engineered vessel Drug Implant [Symvess]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belt Vessel (Daimai) Regulation Acupoint Recipe with electroacupuncture applied to bilateral GB 26 and ST 25, treatment conducted once every other day for 8 weeks
Trial: 15942734
Drug: PrepStart (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PrepStart (combination of Prep and Start)
Trial: 8815279
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy plus glucocorticoids
Trial: 1737529
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (6 separate monthly injections)
Trial: 1737529
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (6 insulin-dependent diabetic subjects treated with human insulin)
Trial: 6385785
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg dexamethasone
Trial: 30137325
Drug: Ovarian stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ovarian stimulation with Clomiphene Citrate (100 mg)
Trial: 27974124
Drug: Low-dose gamma
RxNorm normalized name: gamma-octalactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose gamma globulin (0.2 g/(kg · d)) combined with methylprednisolone
Trial: 27974124
Drug: High-dose gamma
RxNorm normalized name: gamma-octalactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose gamma globulin (0.4 g/(kg · d)) combined with methylprednisolone
Trial: 25232263
Drug: Otilonium bromide
RxNorm normalized name: otilonium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otilonium bromide 80 mg
Trial: 25232263
Drug: Otilonium bromide
RxNorm normalized name: otilonium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otilonium bromide 40 mg
Trial: 7284220
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (6-8ml of 0.5% bupivacaine solution)
Trial: 7284220
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (10-14ml of 0.25% bupivacaine solution)
Trial: 7284220
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (6-8ml of 0.25% bupivacaine solution)
Trial: 29949455
Drug: MABT +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MABT + treatment as usual (TAU)
Trial: 28590363
Drug: dl‐MPH (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dl‐MPH (40 mg) with ethanol (0.6 g/kg)
Trial: 28590363
Drug: d‐MPH (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐MPH (20 mg) with ethanol (0.6 g/kg)
Trial: 28590363
Drug: dl‐MPH (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dl‐MPH (40 mg)
Trial: 28590363
Drug: d‐MPH (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐MPH (20 mg)
Trial: 24809922
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) - aspirin and clopidogrel 75 mg/qd or ticlopidine 500 mg/bid
Trial: 24809922
Drug: Single antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single antiplatelet therapy (ASA) - aspirin only
Trial: 22761759
Drug: 2 single
RxNorm normalized name: ACL2 SINGLE SHOT EPIDURAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 single doses (3.75 µg hemagglutinin)
Trial: 22761759
Drug: 2 double
RxNorm normalized name: Flora-Q 2 Double Strength Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 double doses (7.5 µg hemagglutinin)
Trial: 22761759
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose (control group)
Trial: 20638380
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine (15 mg)
Trial: 20638380
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine (30 mg)
Trial: 12120937
Drug: Premature-delayed vaccination
RxNorm normalized name: adenovirus type 4 vaccine live Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premature-delayed vaccination (first dose when weight of 2,000 g reached)
Trial: 12120937
Drug: Premature vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premature vaccination (first dose within 24 h of birth)
Trial: 12120937
Drug: Full-term vaccination
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-term vaccination (first dose within 24 h of birth)
Trial: 65040
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Bleomycin and Radiotherapy
Trial: 15372414
Drug: 4,000 U
RxNorm normalized name: vitamin D3 14,000 UNT Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4,000 U subcutaneous epoetin alfa
Trial: 15372414
Drug: 10,000 U
RxNorm normalized name: Erwinaze 10,000 UNT Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10,000 U subcutaneous epoetin alfa
Trial: 9274470
Drug: Antibiotics (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (300 mg metronidazole, 500 mg amoxycillin, 250 mg clarithromycin, each given four times daily for two weeks)
Trial: 9274470
Drug: Antibiotics with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics with H pylori clearance
Trial: 9274470
Drug: Antibiotics with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics with H pylori eradication
Trial: 21115933
Drug: finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: finasteride 5 mg/day
Trial: 21115933
Drug: dutasteride 4
RxNorm normalized name: Dutasteride
DrugBank: Dutasteride (DB01126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dutasteride 4 mg/day
Trial: 2872803
Drug: Terazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (1 to 40 mg daily, administered alone or in combination with other antihypertensive agents)
Trial: 24553033
Drug: Group BFM:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group BFM: 0.0625% bupivacaine + 2 μg/ml fentanyl + 2 mg morphine in 15 mL saline
Trial: 24553033
Drug: Group BF:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group BF: 0.1% bupivacaine + 2 μg/mL fentanyl in 15 mL saline
Trial: 20498395
Drug: Carboplatin (AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (AUC 5) plus Pegylated liposomal Doxorubicin (30 mg/m²) every 4 weeks
Trial: 20498395
Drug: Carboplatin (AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (AUC 5) plus Paclitaxel (175 mg/m²) every 3 weeks
Trial: 15099916
Drug: Cyclazocine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclazocine (0.4 mg)
Trial: 15099916
Drug: Cyclazocine (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclazocine (0.8 mg)
Trial: 15099916
Drug: Hydromorphone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone (5 mg)
Trial: 15099916
Drug: Hydromorphone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone (15 mg)
Trial: 15099916
Drug: Cyclazocine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclazocine (0.2 mg)
Trial: 12185409
Drug: Citalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10 mg IV)
Trial: 9824875
Drug: Clozapine titration
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine titration (6-8 weeks)
Trial: 9824875
Drug: Typical antipsychotic
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical antipsychotic drugs (APD)
Trial: 7663868
Drug: Intra-articular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular morphine sulfate 1 mg in normal saline 10 ml
Trial: 7663868
Drug: Intra-articular 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular 0.5% bupivacaine 10 ml
Trial: 2680154
Drug: PQ 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PQ 750 mg with NQ 25 mg
Trial: 2680154
Drug: PYR 600
RxNorm normalized name: pyrilamine maleate 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PYR 600 mg with NQ 25 mg
Trial: 2680154
Drug: PYR 800
RxNorm normalized name: Pyrilamine
DrugBank: Mepyramine (DB06691)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PYR 800 mg with NQ 40 mg
Trial: 2680154
Drug: PYR 800
RxNorm normalized name: Pyrilamine
DrugBank: Mepyramine (DB06691)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PYR 800 mg with NQ 80 mg
Trial: 2680154
Drug: PYR 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PYR 1,200 mg alone
Trial: 25566874
Drug: Self-management intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management intervention (self-monitoring for the first week of each month and individualized treatment self-titration schedule)
Trial: 24165817
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion (TCI) of propofol with alfentanil
Trial: 24165817
Drug: Manually controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manually controlled infusion (MCI) of propofol with alfentanil
Trial: 19364980
Drug: Doxycycline (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (50, 100, or 300 mg/d for 2 weeks)